Artiva Biotherapeutics vs Clene
Artiva Biotherapeutics and Clene are similar in size: $0 and $200,000 of revenue in their latest fiscal years. Clene grew faster (-41.5% against -100.0%).
| Latest fiscal year | Artiva BiotherapeuticsARTV, 2025 | CleneCLNN, 2025 |
|---|---|---|
| Revenue | $0 | $200,000 |
| Revenue growth | -100.0% | -41.5% |
| Net income | −$83.9m | −$26.2m |
| Operating margin | — | — |
| Net margin | — | -13086.5% |
| Return on equity | -56.5% | — |
| Free cash flow | −$79.3m | −$18.6m |
| Cash | $26.7m | $5.2m |
| Total debt | $0 | $17.8m |
| Debt to equity | 0.0% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 104 | 79 |
| Market value | $165m | $47.9m |
| Price vs our value range | — | — |
| Moat score | — | 12 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 1 buys, 62 sales |